Assembly | House | Senate | BLR | Audit

Medicaid drug rebates


​​Increases the Medicaid drug rebate percentage for brand name drugs to 23.1%; increases the Medicaid rebate for non-innovator, multiple source drugs to 13% of average manufacturer price; and extends the drug rebate to Medicaid managed care plans.​